Merge posts big revenue gain
Connectivity firm Merge Technologies reported 55% revenue growth in its first quarter as a public company. The Milwaukee-based software developer credited new product sales and an expanded sales force for the strong performance.For the period
Connectivity firm Merge Technologies reported 55% revenue growth in its first quarter as a public company. The Milwaukee-based software developer credited new product sales and an expanded sales force for the strong performance.
For the period (end-March), Merge posted revenues of $2.6 million, compared with $1.7 million in 1997. The company had a net loss of $56,000, compared with a net loss of $45,000 in the same period last year.
In quarterly highlights, Merge shipped two beta units of its CD-based MergeARK archiving offering. The firm also has been granted a patent for CaseWorks, the first product in Merges line of Networked Image Management offerings, which the company believes will facilitate the development of electronic patient records. CaseWorks is a radiology work-flow management tool that uses a MergeReader hand-held unit to mark films that should be included in a patients EPR. Merge expects CaseWorks to begin shipping in mid-1998.
Since Merges debut on the NASDAQ SmallCap Market in January, the companys stock has seen its share price climb to a high of $7, before falling below its initial public offering price of $6. As of May 4, Merge shares closed at $5.03, down 16.2% from the IPO price.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
